title: [Symptomatic treatment of multiple sclerosis].
abstract: BACKGROUND
  Multiple sclerosis is a chronic neurological disorder which affects middle aged adults. It usually means serious physical, psychological, social and employment problems for the patients concerned.
  
  
  METHODS
  From the anatomo pathological point of view, it is characterized by demyelination and axon damage in the central nervous system. The clinical features are variable, depending on the course of the disease, its clinical form and the sites of the lesions. Symptoms may appear in bouts, as relapses of the disorder or as a result of incomplete recovery from these episodes and cause severe disability.
  
  
  CONCLUSIONS
  We review the physiopathology and most widely used treatment for management of the commonest symptoms of multiple sclerosis.
authors.affiliation: Sección de Neurología, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, España. layusop@meditex.es
authors.forename: L
authors.initials: L
authors.lastname: Ayuso-Peralta
authors.forename: C
authors.initials: C
authors.lastname: de Andrés
mesh_terms: D001259:Ataxia / Q000188:drug therapy; D001418:Baclofen / Q000627:therapeutic use*; D003071:Cognition / Q000502:physiology; D004064:Digestive System / Q000503:physiopathology; D005221:Fatigue / Q000188:drug therapy / Q000503:physiopathology; D018755:GABA Agonists / Q000627:therapeutic use; D006801:Humans; D009103:Multiple Sclerosis / Q000150:complications / Q000473:pathology / Q000503:physiopathology* / Q000628:therapy*; D010146:Pain / Q000188:drug therapy; D012893:Sleep Wake Disorders / Q000188:drug therapy; D014202:Tremor / Q000188:drug therapy; D001750:Urinary Bladder, Neurogenic / Q000188:drug therapy / Q000503:physiopathology; D014717:Vertigo / Q000188:drug therapy
chemical_list: D018755:GABA Agonists; D001418:Baclofen